Kinome Profiling of Cholangiocarcinoma Organoids Reveals Potential Druggable Targets That Hold Promise for Treatment Stratification

Kinase activity in patient-derived cholangiocarcinoma organoids, non-tumorous adjacent tissue-derived and healthy donor-derived intrahepatic cholangiocyte organoids was determined using the PamChip® phosphotyrosine kinase microarray platform.